Search results
Results From The WOW.Com Content Network
Rochford Residents. No overall control. Council control after election. James Newport. Liberal Democrat. No overall control. The 2024 Rochford District Council election took place on 2 May 2024 to elect members of Rochford District Council in Essex, England. [1] This was on the same day as other local elections .
Roche acquired Syntex in 1994, and Chugai Pharmaceuticals in 2002. Oseltamivir an antiviral drug used to combat influenza. Roche is the only drug company authorized to manufacture the drug, which was discovered by Gilead Sciences. Roche purchased the rights to the drug in 1996, and in 2005, settled a royalty dispute, agreeing to pay Gilead ...
Biotechs with clinical-stage weight loss candidates, specifically Viking and Altimmune, fell by nearly 13%, with larger players dropping by more than 4% even while the market was mostly flat.
Therefore, Roche's candidate could probably be taken for longer periods, thereby potentially leading to larger amounts of weight loss. Or, as management pointed out, CT-996 might find a home as a ...
The 2023 Rochford District Council election took place on 4 May 2023 to elect members of Rochford District Council in Essex, England. This would be on the same day as other local elections in England . Less than three months before the election, three Conservative councillors left the party, putting the council under no overall control with the ...
July 17, 2024 at 4:02 AM. By Paolo Laudani and Ludwig Burger. (Reuters) - Roche said on Wednesday a second drug candidate from its purchase of Carmot Therapeutics yielded positive results in an ...
Robert Roche is the co-founder and Executive Chairman of Acorn International Inc., a media and branding direct sales company based in Shanghai, China. He is also the co-founder, Executive Chairman, and President of Oak Lawn Marketing, Inc., a Japan-based company that engages in the TV home shopping business.
By Ludwig Burger. (Reuters) -Roche shares gained as much as 4.7% on Thursday after an early-stage trial showed that a newly-acquired obesity drug candidate led to significant weight loss, a key ...